Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

mebudipine

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Abstract A nanoemulsion drug delivery system was developed to increase the oral bioavailability of mebudipine as a calcium… Expand
2012
2012
Background: Myocardial infarction (MI) is the acute condition of necrosis in myocardium which occurs as a result of imbalance… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2009
2009
In the present study, we investigated the effects of mebudipine and dibudipine, two new Ca(2+) channel blockers, on primary… Expand
2008
2008
The protective effect of two new L-type calcium-channel blockers, mebudipine and dibudipine on neurotoxic effects induced by… Expand
2007
2007
Mebudipine and dibudipine are two newly synthesized dihydropyridine (DHP) calcium channel blockers that have been shown to have… Expand
2004
2004
The prototype 1,4‐dihydropyridine (1,4‐DHP) nifedipine, indicated for the management of hypertension and angina pectoris, has… Expand
2004
2004
In previous studies, mebudipine, a newly synthesized dihydropyridine calcium channel blocker, showed a considerable vasoselective… Expand
2003
2003
Mebudipine and dibudipine are two new dihydropyridine (DHP) Ca2+ channel blockers that have been synthesized by Mahmoudian et al… Expand
1999
1999
Mebudipine and dibudipine are two new dihydropyridine calcium‐channel blockers that have been synthesized in our laboratory. In a… Expand
1997
1997
Dihydropyridine derivative calcium‐channel blockers are widely used in the therapy of hypertension, angina pectoris and other… Expand